Comparison of the efficacy of 10 day-triple therapy-based, bismuth-containing quadruple therapy including lansoprazole with esomeprazole for the first line therapy of Helicobacter pylori

被引：0
|
作者：
Moon, B. S. [1 ]
Lim, H. [1 ]
Lee, S. [1 ]
Lee, Y. [2 ]
机构：
[1] Yonsei Univ, Yongin Severance Hosp, Seoul, South Korea
[2] Yonsei Univ, Severance Hosp, Seoul, South Korea
来源：
HELICOBACTER | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.49
引用
收藏
页数：2
相关论文
共 50 条
  • [21] First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy
    Tarhini, Mandi
    Fayyad-Kazan, Mohammad
    Fayyad-Kazan, Hussein
    Mokbel, Mahmoud
    Nasreddine, Mohammad
    Badran, Bassam
    Kchour, Ghada
    MICROBIAL PATHOGENESIS, 2018, 117 : 23 - 26
  • [22] First-line treatment of helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy
    Tarhini, M.
    Fayyad-Kazan, M.
    Fayyad-Kazan, H.
    Mokbel, M.
    Nasreddine, M.
    Badran, B.
    Kchour, G.
    CLINICA CHIMICA ACTA, 2024, 558
  • [23] Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China
    Lu, Hong
    Zhang, Wei
    Graham, David Y.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (10) : 1134 - 1140
  • [24] The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    Uygun, A.
    Kadayifci, A.
    Safali, M.
    Ilgan, S.
    Bagci, S.
    HELICOBACTER, 2007, 12 (04) : 430 - 430
  • [25] The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    Uygun, Ahmet
    Kadayifci, Abdurrahman
    Safali, Mukerrem
    Ilgan, Seyfettin
    Bagci, Sait
    JOURNAL OF DIGESTIVE DISEASES, 2007, 8 (04) : 211 - 215
  • [26] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Sung Eun Kim
    Moo In Park
    Seun Ja Park
    Won Moon
    Jae Hyun Kim
    Kyoungwon Jung
    Hae Koo Kim
    Young Dal Lee
    World Journal of Gastroenterology, 2017, (06) : 1059 - 1066
  • [27] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Kim, Hae Koo
    Dal Lee, Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (06) : 1059 - 1066
  • [28] Bismuth-based quadruple therapy for Helicobacter pylori -: a single triple capsule plus lansoprazole
    de Boer, WA
    Van Etten, RJXM
    Van de Wouw, BAM
    Schneeberger, PM
    Van Oijen, AHAM
    Jansen, JBMJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (01) : 85 - 89
  • [29] Ten-Day Vonoprazan-Amoxicillin Dual Therapy as a First-Line Treatment of Helicobacter pylori Infection Compared With Bismuth-Containing Quadruple Therapy
    Qian, Hai-Sheng
    Li, Wen-Jie
    Dang, Yi-Ni
    Li, Lu-Rong
    Xu, Xiao-Bing
    Yuan, Lin
    Zhang, Wei-Feng
    Yang, Zhen
    Gao, Xin
    Zhang, Min
    Li, Xuan
    Zhang, Guo-Xin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (04): : 627 - 634
  • [30] RIFABUTIN CONTAINING TRIPLE THERAPY VS. RIFABUTIN AND BISMUTH-CONTAINING QUADRUPLE THERAPY FOR THIRD-LINE TREATMENT OF HELICOBACTER PYLORI (H. PYLORI) INFECTION
    Tavani, R.
    Ciccaglione, A. F.
    Cellini, L.
    Grossi, L.
    Di Tullio, A. M.
    Pagliaro, M.
    Cocciolillo, S.
    Sepe, A.
    Di Berardino, M.
    Marzio, L.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S111 - S111
12345